Hematology Pills
by Mattioli Health
Infection Risk in the Age of CAR-T: Immune Deficiency in Modern…
About this podcast
Hematology Pills is a new format based on monthly discussions between Prof. Robin Foà (Rome) and Dr. Filippo Milano (Seattle). Each episode explores the latest breakthroughs in gene therapy, immunotherapy, and clinical innovation, while addressing also ethical and practical challenges that shape the field. Our podcast offers a clear and compelling look at the evolving landscape of blood disorders and treatments for hematologists, researchers and healthcare professionals. Stay informed, inspired, and connected with Hematology Pills – a source off hematology updates, one episode at a time.
Episodes
- Infection Risk in the Age of CAR-T: Immune Deficiency in Modern Hematology - A Dialogue Between Prof. Robin Foà, Prof. Filippo Milano, and Dr. Joshua A. Hill · 21 min · Season 1 Episode 19In this episode, Prof. Robin Foà and Prof. Filippo Milano are joined by Dr. Joshua A. Hill, infectious disease specialist at Fred Hutchinson Cancer Center in Seattle, to take on…
- Beyond the Storm: Preventing and Managing CAR-T Toxicities – A Dialogue Between Robin Foà, Filippo Milano and Jordan Gauthier · 22 min · Season 1 Episode 18In this episode, Prof. Robin Foà and Prof. Filippo Milano are joined by Dr. Jordan Gauthier, Associate Professor at the Fred Hutchinson Cancer Center and an internationally…
- Fifty Years of Hematopathology: From Morphology to AI · 30 min · Season 1 Episode 17In this episode, Prof. Robin Foà and Dr. Filippo Milano arejoined by Prof. Stefano Pileri, one of the world's leading hematopathologistsand a key contributor to the WHO…
- From CML to AML: Precision Medicine, Global Access, and the Future of Leukemia Care – A Dialogue Between Robin Foà, Filippo Milano and Jerald Radich · 24 min · Season 1 Episode 16In this episode, Prof. Robin Foà, Dr. Filippo Milano, and Dr. Jerald Radich revisit the extraordinary journey of chronic myeloid leukemia (CML), one of the greatest success…
- The Next Chapter of Cord Blood Transplantation: Harnessing Immune Responses to Improve Transplant Outcomes – A dialogue between Robin Foà and Filippo Milano · 23 min · Season 1 Episode 15In this episode, Prof. Robin Foà and Prof. Filippo Milano reflect on a groundbreaking phase two study out of Seattle that introduces a novel and highly effective approach to cord…
- Ph+ ALL without chemotherapy: when TKIs reshape the immune response – A dialogue between Robin Foà, Filippo Milano e Michela Ansuinelli · 27 min · Season 1 Episode 14In this episode, Prof. Robin Foà and Dr. Filippo Milano explore the evolving treatment landscape of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)…
- AI in Hematology and Beyond: Transforming Diagnostics, Research, and Care – A dialogue between Robin Foà and Filippo Milano · 23 min · Season 1 Episode 13In this episode, Prof. Robin Foà and Dr. Filippo Milano explore the rapidly expanding role of Artificial Intelligence in medicine, reflecting on a transformation that feels both…
- Iron Biology Unveiled: Hepcidin, Erythroferrone and the Modern Understanding of Iron Metabolism – A dialogue between Robin Foà, Filippo Milano e Clara Camaschella · 26 min · Season 1 Episode 12In this episode, Prof. Robin Foà and Dr. Filippo Milano are joined by Dr. Clara Camaschella to explore the evolution of iron metabolism, tracing one of the most elegant and…
- The Cost of Progress: Funding, Pharma, and the Future of Hematology – A dialogue between Robin Foà e Filippo Milano · 30 min · Season 1 Episode 11In this episode, Prof. Robin Foà and Dr. Filippo Milano reflect on a striking paradox: while research has revolutionized hematology over the past decades, the sustainability of…
- From chemotherapy to targeted precision: A paradigm shift in the frontline treatment of Ph+ ALL - A dialogue between Robin Foà, Filippo Milano and Sabina Chiaretti · 25 min · Season 1 Episode 10In this episode, Prof. Robin Foà, Prof. Filippo Milano and Prof. Sabina Chiaretti explore the first results of a worldwide randomized phase 3 trial that challenges a…
- The New Era of CLL Therapy: From Chemo-Free Strategies to Fixed-Duration Regimens - A dialogue Between Robin Foà, Filippo Milano and Mazyar Shadman · 23 min · Season 1 Episode 9In this episode, Prof. Robin Foà and Dr. Filippo Milano sit down with Dr. Mazyar Shadman, a leading voice in immunotherapy and one of the foremost experts in chronic lymphocytic…
- Acute Myeloid Leukemia: Progress, Plateau, and the Path Ahead – A Dialogue Between Robin Foà, Filippo Milano and Fred Appelbaum · 23 min · Season 1 Episode 8In this episode, Prof. Robin Foà and Dr. Filippo Milano are joined by Dr. Fred Appelbaum from the Fred Hutchinson Cancer Center to reflect on the persistent challenges and…
- Ph-Positive Acute Lymphoblastic Leukemia, 25 Years of Progress – A Dialogue Between Robin Foà and Filippo Milano · 20 min · Season 1 Episode 7In this episode, Prof. Robin Foà and Dr. Filippo Milano look back on twenty-five years of remarkable progress in the treatment of Philadelphia chromosome-positive acute…
- Evolving Strategies in ALL: CAR-T Cells, MRD, and the Decline of Transplant – A Dialogue Between Robin Foà and Filippo Milano · 14 min · Episode 6In this episode, we delve into the evolving landscape of Acute Lymphoblastic Leukemia (ALL) treatment, with a focus on cutting-edge therapies and their impact on patient…
- Transplant as Immunotherapy: The PTCy Revolution, GVHD Control, and the New Era of Allogeneic SCT – A Dialogue Between Robin Foà and Filippo Milano · 17 min · Season 1 Episode 5In this episode, we delve into the transformative changes in allogeneic stem cell transplantation (SCT), a treatment once seen as a last resort for patients but now experiencing…
- Understanding CAR-T Resistance: Biology, Persistence, and the Pathways to Failure – A Dialogue Between Robin Foà, Filippo Milano, andMarco Ruella · 22 minIn this episode of Hematology Pills, Dr. Marco Ruella, Prof. Robin Foà, and Dr. Filippo Milano dive into the challenges of CAR T-cell therapy resistance. They explore key…
- CAR-T in Multiple Myeloma: Balancing Innovation, Toxicity, and Access – A Dialogue Between Robin Foà, Filippo Milano and Rahul Banerjee · 23 min · Season 1 Episode 4In this episode of Hematology Pills, Professor Robin Foà speaks with Dr. Filippo Milano and Dr. Rahul Banerjee about the current role of CAR-T cell therapy in the treatment of…
- CAR-T Cells: Navigating the Landscape of Access, Sustainability, and Innovation - A Dialogue Between Robin Foà and Filippo Milano · 21 minJoin Prof. Robin Foà (Sapienza University of Rome) and Dr.Filippo Milano (Fred Hutchinson Cancer Center, Seattle) as they explore the evolving landscape of CAR-T cell therapies…
- Gene Therapy: Innovation Meets Access Challenges – A Dialogue Between Robin Foà and Filippo Milano · 22 min · Season 1 Episode 2In the inaugural episode of our hematology podcast, Professor Robin Foà(Emeritus Professor of Hematology, Sapienza University of Rome) and Dr. Filippo Milano (Associate…
- Hematology Pills. Insights into Gene and Immunotherapy - Teaser · 3 min · Season 1 Episode 1Join Prof. Robin Foà (Sapienza University of Rome) and Dr. Filippo Milano (Fred Hutchinson Cancer Center, Seattle) as they explore the cutting-edge world of hematology…








